PALO ALTO, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback